Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Passage Bio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202698.9%
-
Passage Bio Inc. May 19, 202665.2%
-
BioMarin Pharmaceutical Inc. May 20, 202599.0%
-
BioMarin Pharmaceutical Inc. May 21, 202499.6%
-
Passage Bio Inc. May 25, 202390.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| Dec 27, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +2,180 | — | — |
Questions about Athena Countouriotis
What boards is Athena Countouriotis on?
Athena Countouriotis sits on the boards of BioMarin Pharmaceutical Inc., Iovance Biotherapeutics Inc. and Passage Bio Inc.
How long has Athena Countouriotis served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.